BALSARI, ANDREA
BALSARI, ANDREA
Dipartimento di Scienze Biomediche per la Salute
Aerosol 1,25-dihydroxyvitamin D3 supplementation: A strategy to boost anti-tumor innate immune activity
2021 F. Bianchi, M. Sommariva, V. Le Noci, S. Camelliti, N. Gagliano, M. Giussani, A. Balsari, E. Tagliabue, L. Sfondrini
Macrophages impair TLR9 agonist antitumor activity through interacting with the anti-PD-1 antibody Fc domain
2021 S. Camelliti, V. Le Noci, F. Bianchi, C. Storti, F. Arnaboldi, A. Cataldo, S. Indino, E. Jachetti, M. Figini, M.P. Colombo, A. Balsari, N. Gagliano, E. Tagliabue, L. Sfondrini, M. Sommariva
Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer
2021 M. Di Modica, G. Gargari, V. Regondi, A. Bonizzi, S. Arioli, B. Belmonte, L. De Cecco, E. Fasano, F. Bianchi, A. Bertolotti, C. Tripodo, L. Villani, F. Corsi, S. Guglielmetti, A. Balsari, T. Triulzi, E. Tagliabue
The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy
2020 M. Sommariva, V. Le Noci, F. Bianchi, S. Camelliti, A. Balsari, E. Tagliabue, L. Sfondrini
TLR3 expression induces apoptosis in human non‐small‐cell lung cancer
2020 F. Bianchi, S. Alexiadis, C. Camisaschi, M. Truini, G. Centonze, M. Milione, A. Balsari, E. Tagliabue, L. Sfondrini
Targeting Local Microbiota by Antibiotic Therapy Promotes Immunosurveillance against Cancer
2020 L. Sfondrini, V. Le Noci, M. Sommariva, F. Bianchi, S. Camelliti, A. Balsari, E. Tagliabue
Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know
2020 S. Camelliti, V. Le Noci, F. Bianchi, C. Moscheni, F. Arnaboldi, N. Gagliano, A. Balsari, M.C. Garassino, E. Tagliabue, L. Sfondrini, M. Sommariva
Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases
2019 V. Le Noci, M. Sommariva, F. Bianchi, T. Triulzi, E. Tagliabue, A. Balsari, L. Sfondrini
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
2019 G. Fucà, G. Galli, M. Poggi, G. Lo Russo, C. Proto, M. Imbimbo, R. Ferrara, N. Zilembo, M. Ganzinelli, A. Sica, V. Torri, M. Colombo, C. Vernieri, A. Balsari, F. de Braud, M. Garassino, D. Signorelli
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy
2019 T. Triulzi, L. Forte, V. Regondi, M. Di Modica, C. Ghirelli, M.L. Carcangiu, L. Sfondrini, A. Balsari, E. Tagliabue
Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94
2019 F. Caccuri, M. Sommariva, S. Marsico, F. Giordano, A. Zani, A. Giacomini, C. Fraefel, A. Balsari, A. Caruso
Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients
2019 F. Bianchi, M. Milione, P. Casalini, G. Centonze, V.M. Le Noci, C. Storti, S. Alexiadis, M. Truini, G. Sozzi, U. Pastorino, A. Balsari, E. Tagliabue, L. Sfondrini
PD-1 Blockade Promotes Hyperprogressive Disease in NSCLC Through Macrophages Activation via Antibody-Fc/FcR Interaction
2018 G. Sozzi, M. Sommariva, M. Moro, C. Proto, D. Signorelli, M. Ganzinelli, S. Sangaletti, M. Boeri, G. Lo Russo, S. Ferro, E. Tassi, V. Huber, L. Sfondrini, M. Milione, C. Tripodo, M. Colombo, A. Anichini, A. Balsari, L. Rivoltini, M. Garassino
Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases
2018 V. Le Noci, S. Guglielmetti, S. Arioli, C. Camisaschi, F. Bianchi, M. Sommariva, C. Storti, T. Triulzi, C. Castelli, A. Balsari, E. Tagliabue, L. Sfondrini
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-Small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade
2018 G. Lo Russo, M. Moro, M. Sommariva, V. Cancila, M. Boeri, G. Centonze, S. Ferro, M. Ganzinelli, P. Gasparini, V. Huber, M. Milione, L. Porcu, C. Proto, G. Pruneri, D. Signorelli, S. Sangaletti, L. Sfondrini, C. Storti, E. Tassi, A. Bardelli, S. Marsoni, V. Torri, C. Tripodo, M.P. Colombo, A. Anichini, L. Rivoltini, A. Balsari, G. Sozzi, M. Garassino
Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages
2017 M. Sommariva, V. Le Noci, C. Storti, F. Bianchi, E. Tagliabue, A. Balsari, L. Sfondrini
Exploiting poly(I:C) to induce cancer cell apoptosis
2017 F. Bianchi, S. Pretto, E. Tagliabue, A. Balsari, L. Sfondrini
AIRE is expressed and associated with good prognosis in breast cancer
2016 B. Francesca, D.C. Loris, T. Tiziana, R. Sandra, M. Sommariva, C. Storti, A. Piera, T. Elda, A. Balsari, L. Sfondrini
Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells
2016 F. Bianchi, M. Sommariva, L. De Cecco, T. Triulzi, S. Romero Cordoba, E. Tagliabue, L. Sfondrini, A. Balsari
Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor
2016 V.M. LE NOCI, M. Sommariva, M. Tortoreto, N. Zaffaroni, M. Campiglio, E. Tagliabue, A. Balsari, L. Sfondrini